- Release Date: 01/06/21 09:13
- Summary: Positive FDA meetings enable INDs for three Phase 2 trials
- Price Sensitive: Yes
- Download Document 150.7KB
Ann: Positive FDA meetings enable INDs for three Phase 2 trials
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$18.17 |
Change
1.160(6.82%) |
Mkt cap ! $2.143B | |||
| Open | High | Low | Value | Volume |
| $17.48 | $18.44 | $17.48 | $5.705M | 317.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 43 | $18.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.18 | 75 | 1 |
View Market Depth
| Last trade - 10.25am 07/08/2025 (20 minute delay) ? |
| NEU (ASX) Chart |